Cargando…
Global Rise of Depression Prevalence Amid the COVID-19 Pandemic
The immense burden of depressive disorders is on the rise, with global prevalence estimates in 2017 ranging from 4% to 13%. The novel coronavirus SARS-CoV-2 is likely to impact the established risk factors for depressive disorders. Thus, a rapid increase in depression prevalence can be expected amid...
Autores principales: | Egbert, Anna, Karpiak, Stephen, Havlik, Richard, Cankurtaran, Sadiye, Ozturk, Sirinnaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680246/ http://dx.doi.org/10.1093/geroni/igab046.1579 |
Ejemplares similares
-
Global occurrence of depressive symptoms during the COVID-19 pandemic
por: Egbert, Anna Rita, et al.
Publicado: (2023) -
Brain abnormalities in COVID-19 acute/subacute phase: A rapid systematic review
por: Egbert, Anna Rita, et al.
Publicado: (2020) -
Stigma Impacts Health Disparities and Inequities in LGBTQ and People of Color Aging With HIV
por: Egbert, Anna, et al.
Publicado: (2021) -
Failing to Plan Is Planning to Fail: Utilization of Advance Care Directives in Older Adults Living With HIV
por: Nash, Paul, et al.
Publicado: (2021) -
Living With HIV Through the COVID-19 Pandemic: Impacts on Older Adults in New York City
por: Nguyen, Annie, et al.
Publicado: (2021)